H4ZN:XETRA:XETRA-HSBC S&P 500 UCITS ETF USD (Acc) EUR (EUR)

ETF | Others |

Last Closing

USD 53.92

Change

-1.06 (-1.92)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.31 (+0.67%)

USD 102.61B
EUNL:XETRA iShares Core MSCI World UCITS ..

-1.65 (-1.54%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.03 (+0.10%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.02 (+0.13%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

N/A

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.25 (-1.01%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.26 (-1.88%)

USD 23.61B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.97 (-1.78%)

USD 18.97B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.07 (-0.67%)

USD 14.51B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.13 (-0.11%)

USD 12.26B

ETFs Containing H4ZN:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.33% 25% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.33% 25% F 26% F
Trailing 12 Months  
Capital Gain 21.97% 86% B+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.97% 86% B+ 83% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike